Trial Profile
A randomized, single-blind study to evaluate upper gastrointestinal handling of branded versus generic alendronate tablets
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs Alendronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Pharmacokinetics
- Sponsors Merck & Co
- 28 Nov 2006 New trial record.